European Union

Report: Brexit helped U.K. evade EU’s COVID bureaucracy

A new report found Brexit helped the U.K. escape the European Union’s bureaucracy when it came to its handling of the coronavirus. According to the Free Beacon on Thursday, the U.K. was able to approve and administer COVID vaccines and medicines quicker and more efficiently than the EU.

A door sign shows the batch of AstraZeneca vaccine currently used at a vaccination center in Bucharest, Romania, Wednesday, April 7, 2021. British authorities recommended Wednesday that the AstraZeneca COVID-19 vaccine not be given to adults under 30 where possible because of strengthening evidence that the shot may be linked to rare blood clots, a recommendation that came as regulators both in the United Kingdom and the European Union emphasized that the benefits of receiving the vaccine continue to outweigh the risks for most people — even though the European Medicines Agency said it had found a "possible link" between the shot and the rare clots.(AP Photo/Vadim Ghirda)

OAN Newsroom

EU medicine regulator warns of blood clots with Astrazeneca vaccine

The European Union medicine regulator has warned blood clots are a possible side effect of Astrazeneca’s coronavirus vaccine. According to reports Wednesday, the European Medicines Agency said it found the vaccine carries the risk of causing “unusual blood clots.”